GreenPeptide Co., Ltd. Reports Consolidated Earnings Results for the Third Quarter Ended December 31, 2016, Provides Earnings Guidance for the Year Ending March 31, 2017
For the year ending March 31, 2017, the company expects net sales of JPY 406 million, operating loss of JPY 1,306 million, ordinary loss of JPY 1,306 million and net loss of JPY 1,308 million or loss attributable to owners of parents of JPY 41.14 per share.